|

6-Thio-2'-Deoxyguanosine Clinical Trials

1 actively recruiting trial

▼ -1 trial since May 2026

Also known as: 6-thio-dG, THIO, ateganosine

Pipeline

Phase 3: 1

Top Sponsors

  • Maia Biotechnology1

Indications

Other1 trial

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.